In a case study of a prenatal diagnosis of de novo pure trisomy 6p (6p22.3 → p25.3) affected with craniosynostosis and microcephaly, the patient had a 20.88 Mb dosage increase in the genomic region containing the gene BMP6, which led to overexpression of this gene [30]. This evidence concerns the gene BMP6 and microcephaly.